Tseng et al. [217] have revealed that antibodies targeting GRP78 on the surface of tamoxifen-resistant breast cancer MCF-7-LR cells can effectively reduce the cell surface expression of CD44v and cell spreading, thus suggesting a possibility of the attenuation of metastatic potential of the tumor by anti-GRP78 antibodies. Here, HSPA5 is linked to breast carcinoma.